U.S. markets open in 2 hours 59 minutes
  • S&P Futures

    4,205.75
    +11.50 (+0.27%)
     
  • Dow Futures

    34,543.00
    +101.00 (+0.29%)
     
  • Nasdaq Futures

    13,634.75
    +37.00 (+0.27%)
     
  • Russell 2000 Futures

    2,254.50
    +14.60 (+0.65%)
     
  • Crude Oil

    64.63
    -0.08 (-0.12%)
     
  • Gold

    1,821.30
    +5.60 (+0.31%)
     
  • Silver

    27.45
    -0.02 (-0.08%)
     
  • EUR/USD

    1.2083
    +0.0015 (+0.12%)
     
  • 10-Yr Bond

    1.5610
    0.0000 (0.00%)
     
  • Vix

    18.23
    -0.92 (-4.80%)
     
  • GBP/USD

    1.3923
    +0.0031 (+0.22%)
     
  • USD/JPY

    109.1140
    +0.0290 (+0.03%)
     
  • BTC-USD

    56,454.39
    -1,842.21 (-3.16%)
     
  • CMC Crypto 200

    1,474.46
    +3.05 (+0.21%)
     
  • FTSE 100

    7,119.79
    +43.62 (+0.62%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

Global COVID-19 vaccine supply "incredibly tight", COVAX needs funds - Gavi

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

GENEVA, April 15 (Reuters) - The global supply of COVID-19 vaccine is "incredibly tight" and the COVAX dose-sharing facility is unlikely to procure much more supply in 2021 than doses already reserved, the Gavi vaccine alliance ceo Seth Berkley said on Thursday.

"We urgently need commitments of a further $2 billion from donors and $1 billion from countries supported by multilateral development banks. Included in the $2 billion we ask for is $150 million from the private sector," Berkley told an event, referring to a funding target for June.

Stanley Erck, Novavax ceo, said that the U.S.-based company had vaccine production capabilities in more than 20 facilities and that it was "well on our way to securing regulatory authorisations around the world". (Reporting by Stephanie Nebehay in Geneva and Michelle Nichols in New York;)